You have 9 free searches left this month | for more free features.

rebif

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

REbif After Initial Treatment of Multiple Sclerosis (MS)

Terminated
  • Multiple Sclerosis
  • Rebif
  • Darmstadt, Germany
    Please Contact the Merck KGaA Communication Center
Aug 7, 2018

Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in Darmstadt (Rebif)

Completed
  • Relapsing Multiple Sclerosis
  • Clinically Isolated Syndrome
  • Rebif
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center
Mar 29, 2018

Multiple Sclerosis Trial in Rockland (Rebif)

Completed
  • Multiple Sclerosis
  • Rebif
  • Rockland, Massachusetts
    EMD Serono, Inc.
Jan 25, 2018

Patient Real-world Clinical, Neurological, Tolerability, and

Completed
  • Relapsing-remitting Multiple Sclerosis
  • Birmingham, Alabama
  • +22 more
Feb 28, 2018

Multiple Sclerosis Trial in Montpellier (Cholecalciferol (Vitamin D3), Placebo, Rebif)

Completed
  • Multiple Sclerosis
  • Cholecalciferol (Vitamin D3)
  • +2 more
  • Montpellier, France
    CHU Hôpital Gui de Chauliac Service de Neurologie B
May 9, 2017

Healthy Trial in Saint-Petersburg (BCD-054, Rebif, Avonex)

Completed
  • Healthy
  • Saint-Petersburg, Russian Federation
    OOO "BioEk"
Apr 7, 2017

Multiple Sclerosis Trial in Evansville (peginterferon beta-1a, Rebif)

Completed
  • Multiple Sclerosis
  • peginterferon beta-1a
  • Rebif
  • Evansville, Indiana
    Research Site
Jan 29, 2015

Disease Modifying Therapies and Associated Support Services in

Completed
  • Relapsing Multiple Sclerosis
  • Rebif
  • Other: Disease modifying therapies (DMT)
  • Merck KGaA Communication Center for locations, United Kingdom
    Please contact the
May 28, 2015

Relapsing-remitting Multiple Sclerosis Trial in France (Betaferon/Betaseron, Rebif)

Completed
  • Relapsing-remitting Multiple Sclerosis
  • Aix en Provence, France
  • +60 more
Aug 15, 2013

Relapsing-Remitting Multiple Sclerosis Trial (Rebif)

Withdrawn
  • Relapsing-Remitting Multiple Sclerosis
  • Rebif
  • (no location specified)
Aug 4, 2013

Relapsing Remitting Multiple Sclerosis Trial (Glatiramer Acetate, Betaseron, Rebif)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Glatiramer Acetate
  • +2 more
  • (no location specified)
Oct 14, 2010

Multiple Sclerosis Trial in Chapel Hill (Rebif)

Completed
  • Multiple Sclerosis
  • Rebif
  • Chapel Hill, North Carolina
    University of North Carolina-Chapel Hill MS Clinic Within the Ne
Jun 22, 2009